Benefiting Humanity

MBZUAI President, Professor Eric Xing and President of the Weizmann Institute, Professor Alon Chen in Abu Dhabi

A Senior Delegation from the Weizmann Institute of Science Visits MBZUAI Campus in Abu Dhabi

03.05.2021

Math & Computer Science, Computer Vision, Bioinformatics and Computational Biology, Astrophysics, Personalized Medicine, Genetics, Technology & Applications, Benefiting Humanity, Biotechnology

The two parties discussed their new collaboration initiative to advance the field of artificial intelligence research

Prof. Meir Wilchek

An Affinity for Science

11.03.2021

Organic Chemistry, Structural Biology, Biochemistry, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

From refugee child to world-renowned scientist, Prof. Meir Wilchek opened doors to new techniques in research and industry around the globe

Our Customers Want Yellow Bananas

Our Customers Want Yellow Bananas

04.03.2021

Yeda Technology Transfer, Benefiting Humanity

An interview with the CEO of Yeda, Dr. Opher Shapira, who took office in the midst of a pandemic and radical changes in the global economy

Weizmann Institute of Science Ranked Eighth in the World for Research Quality

Weizmann Institute of Science Ranked Eighth in the World for Research Quality

09.11.2020

Benefiting Humanity

In Life and Earth Sciences, the Institute was ranked fourth

bench to bedside

A Faster Path from the Lab Bench to the Clinic

20.05.2020

Yeda Technology Transfer, Benefiting Humanity, Diagnostic Techniques and Drugs

Orchard Innovations is a new joint venture that aims to advance the translation of scientific discovery to the healthcare market

Antibody niche

How to Neutralize the Coronavirus: Learning from the Body

12.05.2020

Viruses & Microorganisms, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Benefiting Humanity, Diagnostic Techniques and Drugs

Making copies of existing antibodies could be fast track to treatment

Irit Sagi

The Israel Institute for Biological Research and the Weizmann Institute of Science Collaborate to Fight Coronavirus

06.05.2020

Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

A milestone in relations between the two institutes could advance a cure

Nir London

Israeli-American-British Labs and Biotech Partner to Speed Coronavirus Drug Development

04.05.2020

Bioinformatics and Computational Biology, Immunology, Disease, Drugs & Diagnostics, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

An international initiative aims to identify compounds that target a key enzyme in the virus's life cycle

Prof. Sarel Fleishman. His research has already led to the design of a potential malaria vaccine, and he is now concentrating his efforts on the coronavirus

Slipping through the Coronavirus's Defense

19.04.2020

Viruses & Microorganisms, Disease, Drugs & Diagnostics, Benefiting Humanity, Diagnostic Techniques and Drugs

Weizmann Institute scientists have developed a research platform for designing tiny antibodies that can halt the virus infection process

Prof. Robert Fluhr, director of the Nancy and Stephen Grand Israel National Center for Personalized Medicine at the Weizmann Institute of Science, receives the first shipment of tests arriving at the Weizmann Institute

The Weizmann Institute of Science Began to Conduct Coronavirus Testing Today

10.04.2020

Viruses & Microorganisms, Disease, Drugs & Diagnostics, Benefiting Humanity

The tests will be carried out at the Nancy and Stephen Grand Israel National Center for Personalized Medicine

Pages

Top Stories

Super cyclones swirling around Jupiter's poles

Jupiter's Super Polar Cyclones are Here to Stay

Stem cells dividing in the bone marrow. Photo credit: Shutterstock

New Blood

Shira Haber

Asya Svirinovsky

Asya Svirinovsky

Press Releases

Jupiter's Super Polar Cyclones are Here to Stay

Following the Footsteps of Humankind out of Africa

Right Off the Bat: Navigation in Extra-Large Spaces